PMV Pharmaceuticals Inc — Quarterly Cash Flow (NASDAQ:PMVP)

Financials

Total assets 191.29 M170.61 M152.85 M133.84 M116.56 M Total liabilities 15.21 M10.5 M12.25 M12.85 M11.85 M Total equity 176.08 M160.11 M140.6 M121 M104.71 M Total liabilities & shareholders' equities 191.29 M170.61 M152.85 M133.84 M116.56 M Total debt ————— Net debt —————

뉴스

PMV Pharma’s rezatapopt study published in New England Journal

OrbiMed, PMV Pharma(PMVP) 주식 152만 달러 상당 매각

OrbiMed Advisors sells PMV Pharma (PMVP) shares for $1.52 million

PMV Pharmaceuticals, Inc. (PMVP) Presents at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - Slideshow (NASDAQ:PMVP) 2025-10-25

PMV 파마슈티컬 주가, 긍정적 암 치료제 임상 데이터에 상승

PMV Pharmaceuticals stock rises on positive cancer drug trial data

PMV Pharma, 암 학회서 TP53 변이 치료 초기 데이터 발표

PMV Pharma to present initial data on TP53 mutation therapy at cancer conference

PMV 제약, H.C. Wainwright ’매수’ 등급 유지: 임상 데이터

PMV Pharmaceuticals stock holds Buy rating at H.C. Wainwright on trial data

PMV Pharmaceuticals, Inc. (PMVP) Special Call - Slideshow (NASDAQ:PMVP)

PMV Pharmaceuticals stock rating reiterated at Buy by TD Cowen